These included EBV-positive Burkitt’s lymphoma cells which also showed increased levels of PI3K pathway activation52, as well as many other refractory lymphoma and leukemia that are frequently relapsed in the clinic. This evidence concerns the gene PIK3CG and Burkitt lymphoma.